ROCKVILLE, Md., March 21, 2014 /PRNewswire/ -- EntreMed, Inc. (ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and other diseases, today reported financial results for the three and 12 months ended December 31, 2013.